Please Wait.....
Report
Long Read Sequencing Market By Techniques (Single-Molecule Real-Time Sequencing, Nanopore Sequencing, Others), By Product (Instruments, Consumables, Services), By Application (Research Applications, Clinical Applications), By End User (Academic and Government Research Institutes, Pharmaceutical and Biotech Companies, Hospitals and Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
Market Report I 2022-08-01 I 322 Pages I Allied Market Research
Long-read sequencing is a class of DNA sequencing technique and is also known the third-generation sequencing. It aids in overcoming and coping with throughput, scope, and accuracy application limits in genomics. In comparison to short-read sequencing, it has a variety of benefits such as short-read sequencing can only create up to 600 bases of DNA, while as long read sequencing technology may produce reads of more than 10,000 bases. Extensive application of this technological environment is expected to result in an improvement in comprehension of evolution of pathogens, cancer, genetic variety, and drug resistance in intricate sections of genome that are crucial for clinical care.
Major factors that drive growth of the global long read sequencing market include rise in utilization of sequence analysis methodologies and surge in demand for genome mapping program. In addition, increase in investments by key players toward R&D related to long-read sequencing technologies and rise in prevalence of genetic disorders and chronic diseases such as cancer further propel the market growth. However, lack of skilled professionals, and ethical and legal limitations are expected to restrain growth of the long-read sequencing market during the forecast period. In addition, nanopore sequencer has a lower read accuracy when compared to short read sequencers, which further hampers growth of the market. Conversely, use of cloud computing as a potential data management service and high growth potential in untapped emerging countries are anticipated to provide lucrative opportunities among the market players.
The long-read sequencing market is segmented on the basis of technology, product, application, end user, and region. By technique, the market is categorized into single-molecule real-time sequencing (SMRT), nanopore sequencing, and others. On the basis of product, it is segmented into instruments, consumables, and services. By application, it is bifurcated into clinical application and research application. By end user, it is segregated into academic & government research institutes, pharmaceutical & biotechnological companies, hospitals & clinics, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Major companies profiled in the report include Agilent Technologies, Inc. BaseClear BV, Cantata Bio, F. Hoffmann-La Roche Ltd., Future Genomics Technologies, The Genome Transcription Facility of Bordeaux, Grandomics, Jiangsu Hengrui Pharmaceutical Co.Ltd., MicrobesNG, Novogene, Oxford Nanopore Technologies, Pacific Biosciences Inc., St Vincent's Hospital Australia, Takara Holdings Inc., Thermo Fisher Scientific, Inc., Element Biosciences, and Illumina, Inc.
Key Benefits For Stakeholders
-This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the long read sequencing market analysis from 2021 to 2031 to identify the prevailing long read sequencing market opportunities.
-The market research is offered along with information related to key drivers, restraints, and opportunities.
-Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
-In-depth analysis of the long read sequencing market segmentation assists to determine the prevailing market opportunities.
-Major countries in each region are mapped according to their revenue contribution to the global market.
-Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
-The report includes the analysis of the regional as well as global long read sequencing market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Application
- Research Applications
- Clinical Applications
By Techniques
- Single-Molecule Real-Time Sequencing
- Nanopore Sequencing
- Others
By Product
- Instruments
- Type
- System
- Software
- Consumables
- Services
By End User
- Academic and Government Research Institutes
- Pharmaceutical and Biotech Companies
- Hospitals and Clinics
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- Agilent Technologies
- BaseClear B.V
- Cantata Bio
- Element bioscience
- F. Hoffmann-La Roche Ltd
- Future Genomics Technologies B.V
- Genome Transcriptome Facility of Bordeaux
- GrandOmics
- JIANGSU HENFRUI PHARMACEUTICALS CO.LTD
- llumina, Inc
- MicrobesNG
- NOVOGENE
- Oxford Nanopore Technologies Limited
- Pacific Biosciences of California, Inc
- Takara Bio, Inc
- Thermo Fisher Scientific, Inc.
- St Vincents Hospital Austrailia
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: LONG READ SEQUENCING MARKET, BY TECHNIQUES
4.1 Overview
4.1.1 Market size and forecast
4.2 Single-Molecule Real-Time Sequencing
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Nanopore Sequencing
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Others
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
CHAPTER 5: LONG READ SEQUENCING MARKET, BY PRODUCT
5.1 Overview
5.1.1 Market size and forecast
5.2 Instruments
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.2.4 Instruments Long Read Sequencing Market by Type
5.2.4.1 System Market size and forecast, by region
5.2.4.2 Software Market size and forecast, by region
5.3 Consumables
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Services
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: LONG READ SEQUENCING MARKET, BY APPLICATION
6.1 Overview
6.1.1 Market size and forecast
6.2 Research Applications
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Clinical Applications
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
CHAPTER 7: LONG READ SEQUENCING MARKET, BY END USER
7.1 Overview
7.1.1 Market size and forecast
7.2 Academic and Government Research Institutes
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Pharmaceutical and Biotech Companies
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
7.4 Hospitals and Clinics
7.4.1 Key market trends, growth factors and opportunities
7.4.2 Market size and forecast, by region
7.4.3 Market analysis by country
7.5 Others
7.5.1 Key market trends, growth factors and opportunities
7.5.2 Market size and forecast, by region
7.5.3 Market analysis by country
CHAPTER 8: LONG READ SEQUENCING MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Techniques
8.2.3 North America Market size and forecast, by Product
8.2.3.1 North America Instruments Long Read Sequencing Market by Type
8.2.4 North America Market size and forecast, by Application
8.2.5 North America Market size and forecast, by End User
8.2.6 North America Market size and forecast, by country
8.2.6.1 U.S.
8.2.6.1.1 Market size and forecast, by Techniques
8.2.6.1.2 Market size and forecast, by Product
8.2.6.1.3 Market size and forecast, by Application
8.2.6.1.4 Market size and forecast, by End User
8.2.6.2 Canada
8.2.6.2.1 Market size and forecast, by Techniques
8.2.6.2.2 Market size and forecast, by Product
8.2.6.2.3 Market size and forecast, by Application
8.2.6.2.4 Market size and forecast, by End User
8.2.6.3 Mexico
8.2.6.3.1 Market size and forecast, by Techniques
8.2.6.3.2 Market size and forecast, by Product
8.2.6.3.3 Market size and forecast, by Application
8.2.6.3.4 Market size and forecast, by End User
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Techniques
8.3.3 Europe Market size and forecast, by Product
8.3.3.1 Europe Instruments Long Read Sequencing Market by Type
8.3.4 Europe Market size and forecast, by Application
8.3.5 Europe Market size and forecast, by End User
8.3.6 Europe Market size and forecast, by country
8.3.6.1 Germany
8.3.6.1.1 Market size and forecast, by Techniques
8.3.6.1.2 Market size and forecast, by Product
8.3.6.1.3 Market size and forecast, by Application
8.3.6.1.4 Market size and forecast, by End User
8.3.6.2 France
8.3.6.2.1 Market size and forecast, by Techniques
8.3.6.2.2 Market size and forecast, by Product
8.3.6.2.3 Market size and forecast, by Application
8.3.6.2.4 Market size and forecast, by End User
8.3.6.3 UK
8.3.6.3.1 Market size and forecast, by Techniques
8.3.6.3.2 Market size and forecast, by Product
8.3.6.3.3 Market size and forecast, by Application
8.3.6.3.4 Market size and forecast, by End User
8.3.6.4 Italy
8.3.6.4.1 Market size and forecast, by Techniques
8.3.6.4.2 Market size and forecast, by Product
8.3.6.4.3 Market size and forecast, by Application
8.3.6.4.4 Market size and forecast, by End User
8.3.6.5 Spain
8.3.6.5.1 Market size and forecast, by Techniques
8.3.6.5.2 Market size and forecast, by Product
8.3.6.5.3 Market size and forecast, by Application
8.3.6.5.4 Market size and forecast, by End User
8.3.6.6 Rest of Europe
8.3.6.6.1 Market size and forecast, by Techniques
8.3.6.6.2 Market size and forecast, by Product
8.3.6.6.3 Market size and forecast, by Application
8.3.6.6.4 Market size and forecast, by End User
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Techniques
8.4.3 Asia-Pacific Market size and forecast, by Product
8.4.3.1 Asia-Pacific Instruments Long Read Sequencing Market by Type
8.4.4 Asia-Pacific Market size and forecast, by Application
8.4.5 Asia-Pacific Market size and forecast, by End User
8.4.6 Asia-Pacific Market size and forecast, by country
8.4.6.1 Japan
8.4.6.1.1 Market size and forecast, by Techniques
8.4.6.1.2 Market size and forecast, by Product
8.4.6.1.3 Market size and forecast, by Application
8.4.6.1.4 Market size and forecast, by End User
8.4.6.2 China
8.4.6.2.1 Market size and forecast, by Techniques
8.4.6.2.2 Market size and forecast, by Product
8.4.6.2.3 Market size and forecast, by Application
8.4.6.2.4 Market size and forecast, by End User
8.4.6.3 India
8.4.6.3.1 Market size and forecast, by Techniques
8.4.6.3.2 Market size and forecast, by Product
8.4.6.3.3 Market size and forecast, by Application
8.4.6.3.4 Market size and forecast, by End User
8.4.6.4 Australia
8.4.6.4.1 Market size and forecast, by Techniques
8.4.6.4.2 Market size and forecast, by Product
8.4.6.4.3 Market size and forecast, by Application
8.4.6.4.4 Market size and forecast, by End User
8.4.6.5 South Korea
8.4.6.5.1 Market size and forecast, by Techniques
8.4.6.5.2 Market size and forecast, by Product
8.4.6.5.3 Market size and forecast, by Application
8.4.6.5.4 Market size and forecast, by End User
8.4.6.6 Rest of Asia-Pacific
8.4.6.6.1 Market size and forecast, by Techniques
8.4.6.6.2 Market size and forecast, by Product
8.4.6.6.3 Market size and forecast, by Application
8.4.6.6.4 Market size and forecast, by End User
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Techniques
8.5.3 LAMEA Market size and forecast, by Product
8.5.3.1 LAMEA Instruments Long Read Sequencing Market by Type
8.5.4 LAMEA Market size and forecast, by Application
8.5.5 LAMEA Market size and forecast, by End User
8.5.6 LAMEA Market size and forecast, by country
8.5.6.1 Brazil
8.5.6.1.1 Market size and forecast, by Techniques
8.5.6.1.2 Market size and forecast, by Product
8.5.6.1.3 Market size and forecast, by Application
8.5.6.1.4 Market size and forecast, by End User
8.5.6.2 Saudi Arabia
8.5.6.2.1 Market size and forecast, by Techniques
8.5.6.2.2 Market size and forecast, by Product
8.5.6.2.3 Market size and forecast, by Application
8.5.6.2.4 Market size and forecast, by End User
8.5.6.3 South Africa
8.5.6.3.1 Market size and forecast, by Techniques
8.5.6.3.2 Market size and forecast, by Product
8.5.6.3.3 Market size and forecast, by Application
8.5.6.3.4 Market size and forecast, by End User
8.5.6.4 Rest of LAMEA
8.5.6.4.1 Market size and forecast, by Techniques
8.5.6.4.2 Market size and forecast, by Product
8.5.6.4.3 Market size and forecast, by Application
8.5.6.4.4 Market size and forecast, by End User
CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments
CHAPTER 10: COMPANY PROFILES
10.1 Agilent Technologies
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 BaseClear B.V
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 Cantata Bio
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 Element bioscience
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 F. Hoffmann-La Roche Ltd
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 Future Genomics Technologies B.V
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 Genome Transcriptome Facility of Bordeaux
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 GrandOmics
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 JIANGSU HENFRUI PHARMACEUTICALS CO.LTD
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 llumina, Inc
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments
10.11 MicrobesNG
10.11.1 Company overview
10.11.2 Company snapshot
10.11.3 Operating business segments
10.11.4 Product portfolio
10.11.5 Business performance
10.11.6 Key strategic moves and developments
10.12 NOVOGENE
10.12.1 Company overview
10.12.2 Company snapshot
10.12.3 Operating business segments
10.12.4 Product portfolio
10.12.5 Business performance
10.12.6 Key strategic moves and developments
10.13 Oxford Nanopore Technologies Limited
10.13.1 Company overview
10.13.2 Company snapshot
10.13.3 Operating business segments
10.13.4 Product portfolio
10.13.5 Business performance
10.13.6 Key strategic moves and developments
10.14 Pacific Biosciences of California, Inc
10.14.1 Company overview
10.14.2 Company snapshot
10.14.3 Operating business segments
10.14.4 Product portfolio
10.14.5 Business performance
10.14.6 Key strategic moves and developments
10.15 Takara Bio, Inc
10.15.1 Company overview
10.15.2 Company snapshot
10.15.3 Operating business segments
10.15.4 Product portfolio
10.15.5 Business performance
10.15.6 Key strategic moves and developments
10.16 Thermo Fisher Scientific, Inc.
10.16.1 Company overview
10.16.2 Company snapshot
10.16.3 Operating business segments
10.16.4 Product portfolio
10.16.5 Business performance
10.16.6 Key strategic moves and developments
10.17 St Vincents Hospital Austrailia
10.17.1 Company overview
10.17.2 Company snapshot
10.17.3 Operating business segments
10.17.4 Product portfolio
10.17.5 Business performance
10.17.6 Key strategic moves and developments
LIST OF TABLES
TABLE 1. GLOBAL LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 2. LONG READ SEQUENCING MARKET SIZE, FOR SINGLE-MOLECULE REAL-TIME SEQUENCING, BY REGION, 2021-2031 ($MILLION)
TABLE 3. LONG READ SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME SEQUENCING, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. LONG READ SEQUENCING MARKET SIZE, FOR NANOPORE SEQUENCING, BY REGION, 2021-2031 ($MILLION)
TABLE 5. LONG READ SEQUENCING MARKET FOR NANOPORE SEQUENCING, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 6. LONG READ SEQUENCING MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 7. LONG READ SEQUENCING MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 8. GLOBAL LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 9. LONG READ SEQUENCING MARKET SIZE, FOR INSTRUMENTS, BY REGION, 2021-2031 ($MILLION)
TABLE 10. LONG READ SEQUENCING MARKET FOR INSTRUMENTS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 11. GLOBAL INSTRUMENTS LONG READ SEQUENCING MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 12. LONG READ SEQUENCING MARKET, FOR SYSTEM, BY REGION, 2021-2031 ($MILLION)
TABLE 13. LONG READ SEQUENCING MARKET, FOR SOFTWARE, BY REGION, 2021-2031 ($MILLION)
TABLE 14. LONG READ SEQUENCING MARKET SIZE, FOR CONSUMABLES, BY REGION, 2021-2031 ($MILLION)
TABLE 15. LONG READ SEQUENCING MARKET FOR CONSUMABLES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 16. LONG READ SEQUENCING MARKET SIZE, FOR SERVICES, BY REGION, 2021-2031 ($MILLION)
TABLE 17. LONG READ SEQUENCING MARKET FOR SERVICES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 18. GLOBAL LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 19. LONG READ SEQUENCING MARKET SIZE, FOR RESEARCH APPLICATIONS, BY REGION, 2021-2031 ($MILLION)
TABLE 20. LONG READ SEQUENCING MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 21. LONG READ SEQUENCING MARKET SIZE, FOR CLINICAL APPLICATIONS, BY REGION, 2021-2031 ($MILLION)
TABLE 22. LONG READ SEQUENCING MARKET FOR CLINICAL APPLICATIONS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 23. GLOBAL LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 24. LONG READ SEQUENCING MARKET SIZE, FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2021-2031 ($MILLION)
TABLE 25. LONG READ SEQUENCING MARKET FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 26. LONG READ SEQUENCING MARKET SIZE, FOR PHARMACEUTICAL AND BIOTECH COMPANIES, BY REGION, 2021-2031 ($MILLION)
TABLE 27. LONG READ SEQUENCING MARKET FOR PHARMACEUTICAL AND BIOTECH COMPANIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 28. LONG READ SEQUENCING MARKET SIZE, FOR HOSPITALS AND CLINICS, BY REGION, 2021-2031 ($MILLION)
TABLE 29. LONG READ SEQUENCING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 30. LONG READ SEQUENCING MARKET SIZE, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 31. LONG READ SEQUENCING MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 32. LONG READ SEQUENCING MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 33. NORTH AMERICA LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 34. NORTH AMERICA LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 35. NORTH AMERICA INSTRUMENTS LONG READ SEQUENCING MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 36. NORTH AMERICA LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 37. NORTH AMERICA LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 38. NORTH AMERICA LONG READ SEQUENCING MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 39. U.S. LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 40. U.S. LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 41. U.S. LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 42. U.S. LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 43. CANADA LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 44. CANADA LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 45. CANADA LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 46. CANADA LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 47. MEXICO LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 48. MEXICO LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 49. MEXICO LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 50. MEXICO LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 51. EUROPE LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 52. EUROPE LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 53. EUROPE INSTRUMENTS LONG READ SEQUENCING MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 54. EUROPE LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 55. EUROPE LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 56. EUROPE LONG READ SEQUENCING MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 57. GERMANY LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 58. GERMANY LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 59. GERMANY LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 60. GERMANY LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 61. FRANCE LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 62. FRANCE LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 63. FRANCE LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 64. FRANCE LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 65. UK LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 66. UK LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 67. UK LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 68. UK LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 69. ITALY LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 70. ITALY LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 71. ITALY LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 72. ITALY LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 73. SPAIN LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 74. SPAIN LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 75. SPAIN LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 76. SPAIN LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 77. REST OF EUROPE LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 78. REST OF EUROPE LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 79. REST OF EUROPE LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 80. REST OF EUROPE LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 81. ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 82. ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 83. ASIA-PACIFIC INSTRUMENTS LONG READ SEQUENCING MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 84. ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 85. ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 86. ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 87. JAPAN LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 88. JAPAN LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 89. JAPAN LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 90. JAPAN LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 91. CHINA LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 92. CHINA LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 93. CHINA LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 94. CHINA LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 95. INDIA LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 96. INDIA LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 97. INDIA LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 98. INDIA LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 99. AUSTRALIA LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 100. AUSTRALIA LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 101. AUSTRALIA LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 102. AUSTRALIA LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 103. SOUTH KOREA LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 104. SOUTH KOREA LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 105. SOUTH KOREA LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 106. SOUTH KOREA LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 107. REST OF ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 108. REST OF ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 109. REST OF ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 110. REST OF ASIA-PACIFIC LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 111. LAMEA LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 112. LAMEA LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 113. LAMEA INSTRUMENTS LONG READ SEQUENCING MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 114. LAMEA LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 115. LAMEA LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 116. LAMEA LONG READ SEQUENCING MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 117. BRAZIL LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 118. BRAZIL LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 119. BRAZIL LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 120. BRAZIL LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 121. SAUDI ARABIA LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 122. SAUDI ARABIA LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 123. SAUDI ARABIA LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 124. SAUDI ARABIA LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 125. SOUTH AFRICA LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 126. SOUTH AFRICA LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 127. SOUTH AFRICA LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 128. SOUTH AFRICA LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 129. REST OF LAMEA LONG READ SEQUENCING MARKET, BY TECHNIQUES, 2021-2031 ($MILLION)
TABLE 130. REST OF LAMEA LONG READ SEQUENCING MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 131. REST OF LAMEA LONG READ SEQUENCING MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 132. REST OF LAMEA LONG READ SEQUENCING MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 133.AGILENT TECHNOLOGIES: COMPANY SNAPSHOT
TABLE 134.AGILENT TECHNOLOGIES: OPERATING SEGMENTS
TABLE 135.AGILENT TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 136.AGILENT TECHNOLOGIES: NET SALES,
TABLE 137.AGILENT TECHNOLOGIES: KEY STRATERGIES
TABLE 138.BASECLEAR B.V: COMPANY SNAPSHOT
TABLE 139.BASECLEAR B.V: OPERATING SEGMENTS
TABLE 140.BASECLEAR B.V: PRODUCT PORTFOLIO
TABLE 141.BASECLEAR B.V: NET SALES,
TABLE 142.BASECLEAR B.V: KEY STRATERGIES
TABLE 143.CANTATA BIO: COMPANY SNAPSHOT
TABLE 144.CANTATA BIO: OPERATING SEGMENTS
TABLE 145.CANTATA BIO: PRODUCT PORTFOLIO
TABLE 146.CANTATA BIO: NET SALES,
TABLE 147.CANTATA BIO: KEY STRATERGIES
TABLE 148.ELEMENT BIOSCIENCE: COMPANY SNAPSHOT
TABLE 149.ELEMENT BIOSCIENCE: OPERATING SEGMENTS
TABLE 150.ELEMENT BIOSCIENCE: PRODUCT PORTFOLIO
TABLE 151.ELEMENT BIOSCIENCE: NET SALES,
TABLE 152.ELEMENT BIOSCIENCE: KEY STRATERGIES
TABLE 153.F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT
TABLE 154.F. HOFFMANN-LA ROCHE LTD: OPERATING SEGMENTS
TABLE 155.F. HOFFMANN-LA ROCHE LTD: PRODUCT PORTFOLIO
TABLE 156.F. HOFFMANN-LA ROCHE LTD: NET SALES,
TABLE 157.F. HOFFMANN-LA ROCHE LTD: KEY STRATERGIES
TABLE 158.FUTURE GENOMICS TECHNOLOGIES B.V: COMPANY SNAPSHOT
TABLE 159.FUTURE GENOMICS TECHNOLOGIES B.V: OPERATING SEGMENTS
TABLE 160.FUTURE GENOMICS TECHNOLOGIES B.V: PRODUCT PORTFOLIO
TABLE 161.FUTURE GENOMICS TECHNOLOGIES B.V: NET SALES,
TABLE 162.FUTURE GENOMICS TECHNOLOGIES B.V: KEY STRATERGIES
TABLE 163.GENOME TRANSCRIPTOME FACILITY OF BORDEAUX: COMPANY SNAPSHOT
TABLE 164.GENOME TRANSCRIPTOME FACILITY OF BORDEAUX: OPERATING SEGMENTS
TABLE 165.GENOME TRANSCRIPTOME FACILITY OF BORDEAUX: PRODUCT PORTFOLIO
TABLE 166.GENOME TRANSCRIPTOME FACILITY OF BORDEAUX: NET SALES,
TABLE 167.GENOME TRANSCRIPTOME FACILITY OF BORDEAUX: KEY STRATERGIES
TABLE 168.GRANDOMICS: COMPANY SNAPSHOT
TABLE 169.GRANDOMICS: OPERATING SEGMENTS
TABLE 170.GRANDOMICS: PRODUCT PORTFOLIO
TABLE 171.GRANDOMICS: NET SALES,
TABLE 172.GRANDOMICS: KEY STRATERGIES
TABLE 173.JIANGSU HENFRUI PHARMACEUTICALS CO.LTD: COMPANY SNAPSHOT
TABLE 174.JIANGSU HENFRUI PHARMACEUTICALS CO.LTD: OPERATING SEGMENTS
TABLE 175.JIANGSU HENFRUI PHARMACEUTICALS CO.LTD: PRODUCT PORTFOLIO
TABLE 176.JIANGSU HENFRUI PHARMACEUTICALS CO.LTD: NET SALES,
TABLE 177.JIANGSU HENFRUI PHARMACEUTICALS CO.LTD: KEY STRATERGIES
TABLE 178.LLUMINA, INC: COMPANY SNAPSHOT
TABLE 179.LLUMINA, INC: OPERATING SEGMENTS
TABLE 180.LLUMINA, INC: PRODUCT PORTFOLIO
TABLE 181.LLUMINA, INC: NET SALES,
TABLE 182.LLUMINA, INC: KEY STRATERGIES
TABLE 183.MICROBESNG: COMPANY SNAPSHOT
TABLE 184.MICROBESNG: OPERATING SEGMENTS
TABLE 185.MICROBESNG: PRODUCT PORTFOLIO
TABLE 186.MICROBESNG: NET SALES,
TABLE 187.MICROBESNG: KEY STRATERGIES
TABLE 188.NOVOGENE: COMPANY SNAPSHOT
TABLE 189.NOVOGENE: OPERATING SEGMENTS
TABLE 190.NOVOGENE: PRODUCT PORTFOLIO
TABLE 191.NOVOGENE: NET SALES,
TABLE 192.NOVOGENE: KEY STRATERGIES
TABLE 193.OXFORD NANOPORE TECHNOLOGIES LIMITED: COMPANY SNAPSHOT
TABLE 194.OXFORD NANOPORE TECHNOLOGIES LIMITED: OPERATING SEGMENTS
TABLE 195.OXFORD NANOPORE TECHNOLOGIES LIMITED: PRODUCT PORTFOLIO
TABLE 196.OXFORD NANOPORE TECHNOLOGIES LIMITED: NET SALES,
TABLE 197.OXFORD NANOPORE TECHNOLOGIES LIMITED: KEY STRATERGIES
TABLE 198.PACIFIC BIOSCIENCES OF CALIFORNIA, INC: COMPANY SNAPSHOT
TABLE 199.PACIFIC BIOSCIENCES OF CALIFORNIA, INC: OPERATING SEGMENTS
TABLE 200.PACIFIC BIOSCIENCES OF CALIFORNIA, INC: PRODUCT PORTFOLIO
TABLE 201.PACIFIC BIOSCIENCES OF CALIFORNIA, INC: NET SALES,
TABLE 202.PACIFIC BIOSCIENCES OF CALIFORNIA, INC: KEY STRATERGIES
TABLE 203.TAKARA BIO, INC: COMPANY SNAPSHOT
TABLE 204.TAKARA BIO, INC: OPERATING SEGMENTS
TABLE 205.TAKARA BIO, INC: PRODUCT PORTFOLIO
TABLE 206.TAKARA BIO, INC: NET SALES,
TABLE 207.TAKARA BIO, INC: KEY STRATERGIES
TABLE 208.THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
TABLE 209.THERMO FISHER SCIENTIFIC, INC.: OPERATING SEGMENTS
TABLE 210.THERMO FISHER SCIENTIFIC, INC.: PRODUCT PORTFOLIO
TABLE 211.THERMO FISHER SCIENTIFIC, INC.: NET SALES,
TABLE 212.THERMO FISHER SCIENTIFIC, INC.: KEY STRATERGIES
TABLE 213.ST VINCENTS HOSPITAL AUSTRAILIA: COMPANY SNAPSHOT
TABLE 214.ST VINCENTS HOSPITAL AUSTRAILIA: OPERATING SEGMENTS
TABLE 215.ST VINCENTS HOSPITAL AUSTRAILIA: PRODUCT PORTFOLIO
TABLE 216.ST VINCENTS HOSPITAL AUSTRAILIA: NET SALES,
TABLE 217.ST VINCENTS HOSPITAL AUSTRAILIA: KEY STRATERGIES
LIST OF FIGURES
FIGURE 1.LONG READ SEQUENCING MARKET SEGMENTATION
FIGURE 2.LONG READ SEQUENCING MARKET,2021-2031
FIGURE 3.LONG READ SEQUENCING MARKET,2021-2031
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.LONG READ SEQUENCING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 12.LONG READ SEQUENCING MARKET,BY TECHNIQUES,2021(%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF SINGLE-MOLECULE REAL-TIME SEQUENCING LONG READ SEQUENCING MARKET,2021-2031(%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF NANOPORE SEQUENCING LONG READ SEQUENCING MARKET,2021-2031(%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF OTHERS LONG READ SEQUENCING MARKET,2021-2031(%)
FIGURE 16.LONG READ SEQUENCING MARKET,BY PRODUCT,2021(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF INSTRUMENTS LONG READ SEQUENCING MARKET,2021-2031(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF CONSUMABLES LONG READ SEQUENCING MARKET,2021-2031(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF SERVICES LONG READ SEQUENCING MARKET,2021-2031(%)
FIGURE 20.LONG READ SEQUENCING MARKET,BY APPLICATION,2021(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF RESEARCH APPLICATIONS LONG READ SEQUENCING MARKET,2021-2031(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF CLINICAL APPLICATIONS LONG READ SEQUENCING MARKET,2021-2031(%)
FIGURE 23.LONG READ SEQUENCING MARKET,BY END USER,2021(%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES LONG READ SEQUENCING MARKET,2021-2031(%)
FIGURE 25.COMPARATIVE SHARE ANALYSIS OF PHARMACEUTICAL AND BIOTECH COMPANIES LONG READ SEQUENCING MARKET,2021-2031(%)
FIGURE 26.COMPARATIVE SHARE ANALYSIS OF HOSPITALS AND CLINICS LONG READ SEQUENCING MARKET,2021-2031(%)
FIGURE 27.COMPARATIVE SHARE ANALYSIS OF OTHERS LONG READ SEQUENCING MARKET,2021-2031(%)
FIGURE 28.LONG READ SEQUENCING MARKET BY REGION,2021
FIGURE 29.U.S. LONG READ SEQUENCING MARKET,2021-2031($MILLION)
FIGURE 30.CANADA LONG READ SEQUENCING MARKET,2021-2031($MILLION)
FIGURE 31.MEXICO LONG READ SEQUENCING MARKET,2021-2031($MILLION)
FIGURE 32.GERMANY LONG READ SEQUENCING MARKET,2021-2031($MILLION)
FIGURE 33.FRANCE LONG READ SEQUENCING MARKET,2021-2031($MILLION)
FIGURE 34.UK LONG READ SEQUENCING MARKET,2021-2031($MILLION)
FIGURE 35.ITALY LONG READ SEQUENCING MARKET,2021-2031($MILLION)
FIGURE 36.SPAIN LONG READ SEQUENCING MARKET,2021-2031($MILLION)
FIGURE 37.REST OF EUROPE LONG READ SEQUENCING MARKET,2021-2031($MILLION)
FIGURE 38.JAPAN LONG READ SEQUENCING MARKET,2021-2031($MILLION)
FIGURE 39.CHINA LONG READ SEQUENCING MARKET,2021-2031($MILLION)
FIGURE 40.INDIA LONG READ SEQUENCING MARKET,2021-2031($MILLION)
FIGURE 41.AUSTRALIA LONG READ SEQUENCING MARKET,2021-2031($MILLION)
FIGURE 42.SOUTH KOREA LONG READ SEQUENCING MARKET,2021-2031($MILLION)
FIGURE 43.REST OF ASIA-PACIFIC LONG READ SEQUENCING MARKET,2021-2031($MILLION)
FIGURE 44.BRAZIL LONG READ SEQUENCING MARKET,2021-2031($MILLION)
FIGURE 45.SAUDI ARABIA LONG READ SEQUENCING MARKET,2021-2031($MILLION)
FIGURE 46.SOUTH AFRICA LONG READ SEQUENCING MARKET,2021-2031($MILLION)
FIGURE 47.REST OF LAMEA LONG READ SEQUENCING MARKET,2021-2031($MILLION)
FIGURE 48. TOP WINNING STRATEGIES, BY YEAR
FIGURE 49. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 50. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 51.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 52.COMPETITIVE DASHBOARD
FIGURE 53.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 54.AGILENT TECHNOLOGIES.: NET SALES ,($MILLION)
FIGURE 55.BASECLEAR B.V.: NET SALES ,($MILLION)
FIGURE 56.CANTATA BIO.: NET SALES ,($MILLION)
FIGURE 57.ELEMENT BIOSCIENCE.: NET SALES ,($MILLION)
FIGURE 58.F. HOFFMANN-LA ROCHE LTD.: NET SALES ,($MILLION)
FIGURE 59.FUTURE GENOMICS TECHNOLOGIES B.V.: NET SALES ,($MILLION)
FIGURE 60.GENOME TRANSCRIPTOME FACILITY OF BORDEAUX.: NET SALES ,($MILLION)
FIGURE 61.GRANDOMICS.: NET SALES ,($MILLION)
FIGURE 62.JIANGSU HENFRUI PHARMACEUTICALS CO.LTD.: NET SALES ,($MILLION)
FIGURE 63.LLUMINA, INC.: NET SALES ,($MILLION)
FIGURE 64.MICROBESNG.: NET SALES ,($MILLION)
FIGURE 65.NOVOGENE.: NET SALES ,($MILLION)
FIGURE 66.OXFORD NANOPORE TECHNOLOGIES LIMITED.: NET SALES ,($MILLION)
FIGURE 67.PACIFIC BIOSCIENCES OF CALIFORNIA, INC.: NET SALES ,($MILLION)
FIGURE 68.TAKARA BIO, INC.: NET SALES ,($MILLION)
FIGURE 69.THERMO FISHER SCIENTIFIC, INC..: NET SALES ,($MILLION)
FIGURE 70.ST VINCENTS HOSPITAL AUSTRAILIA.: NET SALES ,($MILLION)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security